MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $18,652,404.80

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$297.21

▲ +2.87 (0.98%)

As of 06/12/2025 05:00 PM ET

Days: 30 | 90 | 365

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Robert E. Waltermire	VP	Sell	14,113	$341.32	$4,817,049.16	3,728
2/28/2025	Robert E. Waltermire	VP	Sell	1,227	$341.07	$418,492.89	3,728
2/27/2025	James M. Daly	Director	Sell	15,470	$347.45	$5,375,051.50	1,912
1/24/2025	Carole Huntsman	Insider	Sell	347	$335.24	$116,328.28	10,438
1/24/2025	Rebecca Taub	CMO	Sell	648	$335.24	$217,235.52	456,662
1/24/2025	Robert E. Waltermire	VP	Sell	103	$335.24	$34,529.72	4,955
1/24/2025	William John Sibold	CEO	Sell	1,584	$335.24	$531,020.16	54,303
1/17/2025	Rebecca Taub	CMO	Sell	1,689	$273.41	$461,789.49	457,310
1/17/2025	Robert E. Waltermire	VP	Sell	442	$273.41	$120,847.22	5,058
1/17/2025	Shannon T. Kelley	General Counsel	Sell	277	$273.41	$75,734.57	7,705
12/3/2024	Fred B. Craves	Director	Sell	3,600	$315.31	$1,135,116.00	11,000
11/25/2024	Fred B. Craves	Director	Sell	3,400	$350.30	$1,191,020.00	14,600
11/1/2024	Richard S. Levy	Director	Sell	5,000	$300.94	$1,504,700.00	11,012
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757
1/17/2023	Richard S. Levy	Director	Sell	22,489	$293.15	$6,592,650.35	9,100
1/3/2023	Brian Joseph Lynch	SVP	Sell	13,000	$282.92	$3,677,960.00
12/23/2022	Brian Joseph Lynch	SVP	Sell	7,000	$274.18	$1,919,260.00
12/23/2022	Remy Sukhija	insider	Sell	30,000	$274.14	$8,224,200.00

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/29/2025	Rhumbline Advisers	26,364	$8.73M	0.0%	+7.9%	0.119%
5/28/2025	Strs Ohio	1,900	$0.63M	0.0%	N/A	0.009%
5/20/2025	Intech Investment Management LLC	9,784	$3.24M	0.0%	+21.0%	0.044%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	26,363	$8.73M	0.0%	-4.3%	0.119%
5/16/2025	Woodline Partners LP	317,433	$105.14M	0.7%	+2.7%	1.430%
5/16/2025	Goldman Sachs Group Inc.	189,639	$62.81M	0.0%	-21.7%	0.854%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13,858	$4.59M	0.0%	-2.1%	0.062%
5/16/2025	Cinctive Capital Management LP	1,091	$0.36M	0.0%	-79.8%	0.005%
5/16/2025	Cutter Capital Management LP	24,000	$7.95M	3.5%	N/A	0.108%
5/16/2025	AQR Capital Management LLC	3,772	$1.25M	0.0%	-31.2%	0.017%
5/16/2025	Allostery Investments LP	600	$0.20M	0.3%	N/A	0.003%
5/16/2025	Adage Capital Partners GP L.L.C.	191,609	$63.47M	0.1%	+860.0%	0.863%
5/16/2025	ADAR1 Capital Management LLC	1,490	$0.49M	0.1%	N/A	0.007%
5/15/2025	MPM Bioimpact LLC	100,415	$33.26M	5.7%	N/A	0.452%
5/15/2025	EP Wealth Advisors LLC	604	$0.20M	0.0%	N/A	0.003%
5/15/2025	Paulson & CO. Inc.	2,099,523	$695.43M	39.8%	+2.8%	9.456%
5/15/2025	Braidwell LP	48,690	$16.13M	0.6%	N/A	0.219%
5/15/2025	Royal Bank of Canada	8,819	$2.92M	0.0%	-22.6%	0.040%
5/15/2025	Propel Bio Management LLC	30,032	$9.95M	11.6%	-30.2%	0.135%
5/15/2025	Quarry LP	700	$0.23M	0.1%	N/A	0.003%
5/15/2025	Nomura Holdings Inc.	1,692	$0.56M	0.0%	-176.9%	0.008%
5/15/2025	Tema Etfs LLC	2,278	$0.76M	0.2%	-37.1%	0.010%
5/15/2025	Tri Locum Partners LP	37,869	$12.54M	6.4%	-20.2%	0.171%
5/15/2025	Landscape Capital Management L.L.C.	6,707	$2.22M	0.2%	+85.1%	0.030%
5/14/2025	Affinity Asset Advisors LLC	80,000	$26.50M	2.5%	-3.0%	0.360%
5/14/2025	Rafferty Asset Management LLC	29,902	$9.90M	0.0%	-9.7%	0.135%
5/14/2025	Corebridge Financial Inc.	8,807	$2.92M	0.0%	-1.5%	0.040%
5/14/2025	Comerica Bank	783	$0.26M	0.0%	+12.0%	0.004%
5/14/2025	MetLife Investment Management LLC	10,453	$3.46M	0.0%	-3.4%	0.047%
5/14/2025	University of Wisconsin Foundation	48,376	$16.02M	12.4%	+16.5%	0.218%
5/14/2025	Price T Rowe Associates Inc. MD	542,633	$179.74M	0.0%	-7.8%	2.444%
5/14/2025	Martingale Asset Management L P	5,544	$1.84M	0.0%	-6.3%	0.025%
5/14/2025	Candriam S.C.A.	21,372	$7.08M	0.0%	N/A	0.096%
5/14/2025	Dorsey & Whitney Trust CO LLC	791	$0.26M	0.0%	-5.2%	0.004%
5/14/2025	Groupama Asset Managment	33,452	$10.97M	0.1%	+37.5%	0.151%
5/14/2025	BI Asset Management Fondsmaeglerselskab A S	146	$48K	0.0%	-72.5%	0.001%
5/14/2025	Wellington Management Group LLP	7,628	$2.53M	0.0%	-6.7%	0.034%
5/13/2025	Northern Trust Corp	150,886	$49.98M	0.0%	-3.2%	0.680%
5/13/2025	Summit Securities Group LLC	100	$33K	0.0%	N/A	0.000%
5/13/2025	Raymond James Financial Inc.	53,916	$17.86M	0.0%	+0.1%	0.243%
5/13/2025	American Century Companies Inc.	158,306	$52.44M	0.0%	+15.7%	0.713%
5/13/2025	Sei Investments Co.	10,104	$3.16M	0.0%	+22.8%	0.046%
5/13/2025	Lord Abbett & CO. LLC	118,024	$39.09M	0.1%	+141.3%	0.532%
5/13/2025	E Fund Management Co. Ltd.	2,795	$0.93M	0.0%	+18.7%	0.013%
5/13/2025	Caitong International Asset Management Co. Ltd	429	$0.14M	0.1%	+304.7%	0.002%
5/13/2025	Russell Investments Group Ltd.	29,574	$9.80M	0.0%	+1,895.5%	0.133%
5/13/2025	Informed Momentum Co LLC	14,557	$4.82M	0.8%	N/A	0.066%
5/13/2025	HighTower Advisors LLC	1,423	$0.47M	0.0%	-15.1%	0.006%
5/12/2025	Nuveen LLC	49,922	$16.54M	0.0%	N/A	0.225%
5/12/2025	Entropy Technologies LP	1,102	$0.37M	0.0%	N/A	0.005%
5/12/2025	Invesco Ltd.	132,934	$44.03M	0.0%	+3.0%	0.599%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	102,360	$33.91M	0.1%	-0.9%	0.461%
5/12/2025	Tao Capital Management LP	112,785	$37.36M	32.2%	-13.6%	0.508%
5/12/2025	Swiss National Bank	25,400	$8.41M	0.0%	-0.8%	0.114%
5/9/2025	Deutsche Bank AG	25,940	$8.59M	0.0%	-40.6%	0.117%
5/9/2025	Chicago Partners Investment Group LLC	835	$0.28M	0.0%	N/A	0.004%
5/9/2025	Charles Schwab Investment Management Inc.	151,251	$50.10M	0.0%	+0.3%	0.681%
5/9/2025	Vanguard Group Inc.	1,690,111	$559.82M	0.0%	-0.9%	7.612%
5/9/2025	American Assets Investment Management LLC	4,500	$1.49M	0.1%	N/A	0.020%
5/9/2025	JGP Global Gestao de Recursos Ltda.	1,241	$0.41M	0.3%	-37.7%	0.006%
5/9/2025	Accent Capital Management LLC	75	$25K	0.0%	N/A	0.000%
5/9/2025	Earned Wealth Advisors LLC	2,422	$0.80M	0.2%	N/A	0.011%
5/9/2025	Blair William & Co. IL	1,003	$0.33M	0.0%	N/A	0.005%
5/9/2025	J. Safra Sarasin Holding AG	1,792	$0.59M	0.0%	-47.4%	0.008%
5/9/2025	Kazazian Asset Management LLC	955	$0.32M	0.3%	-81.8%	0.004%
5/8/2025	Blueshift Asset Management LLC	1,226	$0.41M	0.2%	N/A	0.006%
5/8/2025	First National Trust Co	8,014	$2.65M	0.1%	+126.1%	0.036%
5/8/2025	XTX Topco Ltd	1,184	$0.39M	0.0%	N/A	0.005%
5/8/2025	Federated Hermes Inc.	58,025	$19.22M	0.0%	N/A	0.261%
5/7/2025	Fiera Capital Corp	132,179	$43.78M	0.2%	+23.0%	0.595%
5/7/2025	Carrera Capital Advisors	3,749	$1.24M	0.3%	+15.6%	0.017%
5/7/2025	LPL Financial LLC	30,822	$10.21M	0.0%	+490.5%	0.139%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	2,138	$0.71M	0.0%	-12.0%	0.010%
5/7/2025	TD Asset Management Inc	22,240	$7.37M	0.0%	-15.5%	0.100%
5/7/2025	Skandinaviska Enskilda Banken AB publ	3,978	$1.32M	0.0%	-49.0%	0.018%
5/7/2025	Knights of Columbus Asset Advisors LLC	3,867	$1.28M	0.1%	-17.6%	0.017%
5/6/2025	Assetmark Inc.	5,183	$1.72M	0.0%	+24.0%	0.023%
5/6/2025	Cetera Investment Advisers	2,832	$0.94M	0.0%	-1.7%	0.013%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	1,969	$0.65M	0.0%	N/A	0.009%
5/6/2025	VSM Wealth Advisory LLC	75	$25K	0.0%	N/A	0.000%
5/5/2025	Allianz Asset Management GmbH	1,556	$0.52M	0.0%	+59.1%	0.007%
5/2/2025	Victory Capital Management Inc.	68,390	$22.65M	0.0%	-3.2%	0.310%
5/1/2025	CWM LLC	2,612	$0.87M	0.0%	+12.1%	0.012%
5/1/2025	Emerald Advisers LLC	47,909	$15.87M	0.7%	+75.7%	0.217%
5/1/2025	New York State Common Retirement Fund	44,771	$14.83M	0.0%	+9.7%	0.203%
5/1/2025	Mutual of America Capital Management LLC	11,263	$3.73M	0.0%	+0.3%	0.051%
5/1/2025	Emerald Mutual Fund Advisers Trust	35,238	$11.67M	0.8%	+88.9%	0.160%
5/1/2025	Xponance Inc.	1,359	$0.45M	0.0%	+7.2%	0.006%
4/30/2025	Cerity Partners LLC	1,411	$0.47M	0.0%	-3.8%	0.006%
4/30/2025	China Universal Asset Management Co. Ltd.	4,429	$1.47M	0.1%	-4.2%	0.020%
4/29/2025	Envestnet Asset Management Inc.	15,270	$5.06M	0.0%	+1.8%	0.069%
4/29/2025	Bank of New York Mellon Corp	60,789	$20.14M	0.0%	+1.0%	0.275%
4/29/2025	GF Fund Management CO. LTD.	558	$0.19M	0.0%	+21.8%	0.003%
4/28/2025	D.A. Davidson & CO.	2,173	$0.72M	0.0%	+203.9%	0.010%
4/28/2025	Principal Financial Group Inc.	1,434	$0.48M	0.0%	-6.3%	0.006%
4/28/2025	Teacher Retirement System of Texas	3,522	$1.17M	0.0%	-8.7%	0.016%
4/28/2025	First Horizon Advisors Inc.	157	$52K	0.0%	+38.9%	0.001%
4/28/2025	Cannon Global Investment Management LLC	1,500	$0.50M	0.9%	N/A	0.007%
4/25/2025	Verity Asset Management Inc.	1,560	$0.52M	0.2%	+4.7%	0.007%
4/24/2025	Mirae Asset Global Investments Co. Ltd.	70,341	$23.29M	0.1%	+0.2%	0.319%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $297.21

$288.19

$303.45

50 Day Range

MA: $297.71

$267.56

$340.80

52 Week Range

Now: $297.21

$200.63

$377.46

Volume

378,417 shs

Average Volume

364,308 shs

Market Capitalization

$6.60 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Carole Huntsman (Insider)
Shannon T Kelley (General Counsel)
Robert E Waltermire (VP)
James M Daly (Director)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Paulson & CO. Inc. — 9.46%
Vanguard Group Inc. — 7.61%
Price T Rowe Associates Inc. MD — 2.44%
Woodline Partners LP — 1.43%
Adage Capital Partners GP L.L.C. — 0.86%
Goldman Sachs Group Inc. — 0.85%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Jane Street Group LLC
Jane Street Group LLC
Susquehanna International Group LLP
Caption Management LLC
Goldman Sachs Group Inc.
HAP Trading LLC
Price T Rowe Associates Inc. MD
Handelsbanken Fonder AB
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Bros Advisors Lp Baker (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Brian Joseph Lynch (SVP)
Richard S Levy (Director)
Carole Huntsman (Insider)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
Adage Capital Partners GP L.L.C.
MPM Bioimpact LLC
Lord Abbett & CO. LLC
Federated Hermes Inc.
Paulson & CO. Inc.
Nuveen LLC
Braidwell LP
GAMMA Investing LLC